In response, this investigation focused on the correlation between SNPs within TLR4 and BPH risk by feat of multifactor dimensionality reduction (MDR) model (12), which might offer evidences for efficacious diagnosis and treatment for BPH. Here, TLR4 is linked to benign prostatic hyperplasia.